Boston Scientific's China Growth 25% Year to Date: CEO
May 1 -- Michael Mahoney, chief executive officer of Boston Scientific Corp., talks about the company's plans to boost growth and profit margins by cutting costs, introducing new devices and expanding globally. Mahoney, speaking with Alix Steel on Bloomberg Television's "Street Smart," also discusses Boston Scientific's share buyback program and the outlook for the medical-device industry.
Most Recent Videos
South32 CEO Kerr Says Company Had Strong Production Year
27:46 - South32 CEO Graham Kerr discusses the company's performance and talks about his outlook for commodities. He speaks on "Bloomberg Markets: Middle East." (Source: Bloomberg)